Skip to content

Howard G. Welgus, Director at Arcutis Biotherapeutics, sold ARQT on Jun 17, 2026

Data as of Oct 16

▼ SELL$16.3K635 shares at $25.67Howard G. Welgus DirectorARQT Arcutis Biotherapeutics, Inc.
Watch ARQT
Traded
Jun 17, 2026
Disclosed
Jun 17, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Howard G. Welgus, Director at Arcutis Biotherapeutics, sold ARQT on Jun 17, 2026TRADEDDISCLOSED
ARQTSimilar stocks (XLV — its sector index fund), rebased to ARQT's price on the disclosure day
ARQT since disclosure
+9.9%
after the sale
Similar stocks (XLV) since disclosure
+17.3%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHoward G. Welgus DirectorARQT Arcutis Biotherapeutics, Inc.$100Kdisclosed Jun 17 · filed 2 days after the trade

See every trade on ARQT →